Emily Mui

Stanford Antimicrobial Safety & Sustainability Program @StanfordASP

[Stanford Antimicrobial Stewardship @StanfordASP]

Great session at #IDWeek24 with our very own at @StanDeresinski discussing challenging diagnostic cases in ID ⭐️

cc: @Stanford_ID @IDWeekmtg @IDSAInfo @SHEA_Epi @PIDSociety @SIDPharm

[David Ha @DHpharmd]

Happy #IDPharmacistsDay to my brilliant colleagues @Willeeuhmm @EmilyMui @LinaMengPharmD at @StanfordASP @Stanford_ID and our partners @StanfordPedsASP @LPthePharmD! 🙌🏼🤩

#SIDPAdvocacy #JointheAMRFight

[Open Forum Infectious Diseases @OFIDJournal]

Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience

✅ Just Accepted
🔓 Open Access
🔗 https://t.co/GUy80YSc3K

@DHpharmd @jessicawithID @Pharm_Bean @EmilyMui @StanDeresinski @Marisa_Holubar @Willeeuhmm

[ACCP INFD PRN @accpinfdprn]

Invasive mucormycosis is an uncommon infix that has been associated with high rates of mortality. Differences in pt host factors, dx presentation, and mgmt practices have made it difficult to ascertain efficacy of interventions with invasive mucormycosis. @MAD_ID_ASP #MADID2023

[Ralph Tayyar @RalphTayyarMD]

So proud of our one and only Dr. David Ha discussing antimicrobial stewardship in intraabdominal infections @DHpharmd @Stanford_Med_ID #SHEASpring2023

[David Ha @DHpharmd]

So proud of our ⭐ brilliant ⭐ @Stanford_ID fellows @AlexZimmet @RalphTayyarMD and Krithi Srinivasan presenting research at #SHEASpring2023! Rock stars! 🤩

[Stanford Antimicrobial Stewardship @StanfordASP]

📢 We are proud to announce the launch of our Outpatient Antibiotic Guidebook! 💊📖 #IDTwitter #MedEd @StanfordDeptMed @StanfordMed @StanfordHealth @Stanford_ID @Stanford_Med_ID
https://t.co/RzxQpwvOkQ

[David Ha @DHpharmd]

A daily thought of mine is how spoiled we are with such amazing ID fellows, ♥️ you folks! ☺️ @Stanford_ID @Stanford_Med_ID

[Will A @Willeeuhmm]

📢 Poll Question

In liver transplant recipients, what duration of abx surgical ppx does your institution recommend?

Feel free to comment below if you provide diff recs based on patient-specific factors (MELD, amount of RBC transfused, choledochojejunostomy, etc)

[Stanford Infectious Diseases Program @Stanford_ID]

We are so excited to gain such an incredible new class of incoming fellows today! Congratulations to each of you on all you have already accomplished. We cannot wait for you to join our Stanford ID family in a few short months!

[David Ha @DHpharmd]

✅ Check out this work on persistent VRE bacteremia 🦠🩸➡️🦠🩸 led by the wonderful @FoxEPharmD and @Willeeuhmm with our @StanfordASP @Stanford_ID team @StanDeresinski @Marisa_Holubar @EmilyMui @LinaMengPharmD and Twitter-less Mark Bounthavong. 🥳🎉🙌

https://t.co/TK4AEH86bE

[Stanford Antimicrobial Stewardship @StanfordASP]

Interested in risk factors associated with persistent VRE bacteremia?

Check this out from our former ID PGY2 @StanfordMed and 🌟 ID PharmD @MDAndersonNews 👏🏽

https://t.co/zyUNDYLA4S

[Will A @Willeeuhmm]

Great work, @FoxEPharmD!

“Patients with severe neutropenia, 4 out of 4 positive index blood culture bottles, and lack of source control were more likely to develop persistent VRE bacteremia despite directed antibiotic treatment.” @StanfordASP @Stanford_ID @MDAndersonNews

[Contagion @Contagion_Live]

Dr. Brian Lu @Willeeuhmm and @DHpharmd @StanfordASP offer insights on combination #antifungal therapy for treatment of invasive #mucormycosis
#IDTwitter @MAD_ID_ASP

https://t.co/AXwdM5j380

[Contagion @Contagion_Live]

There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive #mucormycosis

https://t.co/AXwdM5j380

[Stanford Pediatric Infectious Diseases Fellowship @LPCH_IDProgram]

Our very own ID pharmacist and steward Laura Bio @StanfordPedsASP co-moderating her session on New Frontiers in Pediatric ASP @IDWeek2022 #IDweek2022 @PIDSociety

[Jorge Luis Salinas @jlsalinas7]

Nice work from @Stanford_Med_ID colleagues @DHpharmd @StanDeresinski

[Stanford Antimicrobial Stewardship @StanfordASP]

Great session on optimizing antimicrobial stewardship in challenging populations. Check out the shoutout to our very own @Willeeuhmm work in high-risk AML patients 🤒 🧫 👀 @IDWeek2022 @SIDPharm

[Will A @Willeeuhmm]

First time as a speaker @IDWeek2022! Couldn’t have done it without the support of so many mentors.

Also great to reconnect w/ colleagues from across the country and meet new friends that are absolutely killing it at their institutions! @StanfordASP @SIDPharm

📸: @HMS_MI

[Stanford Pediatric ASP @StanfordPedsASP]

#ASP #Pharmacist presence on #infectiousdiseases rounds results in more interventions. Shoutout to the best ASP Pharmacists, Dr. Laura Bio & @LPthePharmD! #idweek2022 @LPCH_IDProgram